PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 1.380
+0.005 (0.36%)
Sep 29, 2025, 4:10 PM AEST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 949.91 million as of September 26, 2025. Its market cap has decreased by -46.69% in one year.
Market Cap
949.91M
Enterprise Value
933.46M
Revenue
128.70M
Ranking
n/a
PE Ratio
72.76
Stock Price
1.38
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 949.91M, an increase of 2,770.93%. That is a compound annual growth rate of 13.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 949.91M | -32.60% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | 2.57B | 96.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 93.96B |
| Pro Medicus | 31.54B |
| Cochlear | 18.31B |
| Sonic Healthcare | 10.45B |
| Ramsay Health Care | 7.31B |
| Telix Pharmaceuticals | 5.03B |
| Ansell | 4.57B |
| Mesoblast | 3.07B |